VetEmbryo ApS Financials, key figures and credit report
Gross profit 2 322.3 kDKK FY 2025 +20.8% vs 2024
EBIT 294.7 kDKK FY 2025 +36% vs 2024
Net debt - 840.5 kDKK FY 2025 -19.5% vs 2024
Quick ratio 1.3 FY 2025 +0.4 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 636.64 | 2 331.56 | 1 803.28 | 1 922.39 | 2 322.30 |
| Employee benefit expenses | -1 134.24 | -1 923.87 | -1 571.43 | -1 467.13 | -1 850.35 |
| Total depreciation | - 156.29 | - 187.59 | - 219.91 | - 238.64 | - 177.28 |
| EBIT | 346.11 | 220.10 | 11.94 | 216.62 | 294.66 |
| Other financial income | 0.71 | 0.05 | 0.14 | 19.17 | 5.53 |
| Other financial expenses | -18.99 | -16.17 | -10.85 | -18.62 | -13.17 |
| Pre-tax profit | 327.83 | 203.99 | 1.23 | 217.17 | 287.03 |
| Income taxes | -52.24 | -45.53 | -0.74 | -47.91 | -63.21 |
| Net earnings | 275.60 | 158.46 | 0.50 | 169.26 | 223.82 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 519.59 | 612.20 | 579.36 | 409.22 | 231.94 |
| Tangible assets total | 519.59 | 612.20 | 579.36 | 409.22 | 231.94 |
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 43.58 | 62.13 | 66.23 | 120.96 | 93.11 |
| Finished products/goods | 36.50 | 64.80 | 134.30 | 150.31 | 160.31 |
| Inventories total | 80.08 | 126.93 | 200.53 | 271.27 | 253.42 |
| Current trade debtors | 230.55 | 220.33 | 321.07 | 227.21 | 330.54 |
| Prepayments and accrued income | 1.72 | 1.71 | |||
| Current other receivables | 112.50 | 83.50 | |||
| Current deferred tax assets | 10.21 | 48.92 | 119.18 | ||
| Short term receivables total | 230.55 | 220.33 | 443.78 | 361.35 | 451.43 |
| Cash and bank deposits | 141.11 | 213.28 | 84.72 | 703.21 | 840.53 |
| Cash and cash equivalents | 141.11 | 213.28 | 84.72 | 703.21 | 840.53 |
| Balance sheet total (assets) | 971.34 | 1 172.74 | 1 308.39 | 1 745.06 | 1 777.32 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 |
| Retained earnings | -68.49 | 207.11 | 365.57 | 366.07 | 535.33 |
| Profit of the financial year | 275.60 | 158.46 | 0.50 | 169.26 | 223.82 |
| Shareholders equity total | 258.11 | 416.57 | 417.07 | 586.33 | 810.15 |
| Provisions | 11.50 | 11.23 | 4.17 | ||
| Non-current liabilities total | |||||
| Current trade creditors | 22.00 | 156.59 | 238.67 | 259.54 | 101.59 |
| Current owed to participating | 372.02 | 379.53 | 406.24 | ||
| Short-term deferred tax liabilities | 55.84 | 45.80 | |||
| Other non-interest bearing current liabilities | 251.87 | 163.02 | 242.24 | 899.19 | 865.58 |
| Current liabilities total | 701.73 | 744.94 | 887.15 | 1 158.73 | 967.17 |
| Balance sheet total (liabilities) | 971.34 | 1 172.74 | 1 308.39 | 1 745.06 | 1 777.32 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated